Comparing treatment strategies for placental site trophoblastic tumour (PSTT): study protocol for a systematic review and network meta-analysis.

ABSTRACT: Placental site trophoblastic tumour (PSTT) is a rare type of gestational trophoblastic malignancy. Despite different guidelines recommending surgery, chemotherapy or immunotherapy, there has been no optimal first-line treatment owing to its rarity. Direct comparisons of efficacy and safety across interventions remain limited. We aim to perform a systematic review and network meta-analysis (NMA) to explore each PSTT treatment and to help develop individualised, evidence-based clinical decisions. This systematic review, registered on PROSPERO and adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-P 2015 guidelines, will evaluate all available treatments for PSTT. Databases (PubMed, Scopus, Embase, Web of Science) will be searched from inception to 31 May

SUBMITTER: Ma J 

PROVIDER: S-EPMC12382574 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature